186 results
Page 2 of 10
6-K
EX-99.2
cnxl nxvkxf
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.1
xcipex 47
25 Oct 22
Current report (foreign)
12:27pm
20-F/A
uz4v6u
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
uu4lhtbhzk70
6 Sep 22
RepliCel Announces Non-brokered Private Placement
2:35pm
6-K
EX-99.1
6f9bhu73fwfuvosv 56
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
soxs5
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.1
r10r8dpmob5b0
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.2
1dkuf d34
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.3
auu pzhy8ijcgfy8
4 Aug 22
Current report (foreign)
11:41am
6-K
EX-99.1
mcz81
28 Jul 22
Current report (foreign)
2:52pm
6-K
EX-99
7ucd7xd45dr3251
26 Jul 22
Independent Laboratory Test Results Confirm Value of DermaPreciseTM Injection Consistency in Clinical Simulation Testing
1:45pm
6-K
EX-99.1
fcxz46ezukpot
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
5y0kgxiumg5
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.4
19hp dvp47ib
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
xd24jfm cr
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.4
nlod4bajf fz5
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
6-K
EX-99.1
en8ga jtzhkgbtap
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.1
x2ey tte34
29 Mar 22
RepliCel Announces Material Patent Milestones
12:51pm
6-K
EX-99.2
kyvd ceof01c7qab
21 Dec 21
51-102F3 Material Change Report
5:28pm